Cargando…
Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun- and lyophilized formulations
Veklury™ by Gilead Sciences, Inc., containing antiviral drug, remdesivir (REM) has received emergency authorization in the USA and in Europe for COVID-19 therapy. Here, for the first time, we describe details of the non-covalent, host-guest type interaction between REM and the solubilizing excipient...
Autores principales: | Szente, Lajos, Puskás, István, Sohajda, Tamás, Varga, Erzsébet, Vass, Panna, Nagy, Zsombor Kristóf, Farkas, Attila, Várnai, Bianka, Béni, Szabolcs, Hazai, Eszter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025548/ https://www.ncbi.nlm.nih.gov/pubmed/33910715 http://dx.doi.org/10.1016/j.carbpol.2021.118011 |
Ejemplares similares
-
Molecular interactions in remdesivir-cyclodextrin systems
por: Várnai, Bianka, et al.
Publicado: (2022) -
Sulfobutylether-β-cyclodextrin
por: Stella, Valentino J., et al.
Publicado: (2020) -
Entropy-Driven Inclusion of Natural Protoberberine Alkaloids in Sulfobutylether-β-Cyclodextrin
por: Miskolczy, Zsombor, et al.
Publicado: (2022) -
Testing the Protective Effects of Sulfobutylether-Βeta-Cyclodextrin (SBECD) and Sugammadex against Chlorpromazine-Induced Acute Toxicity in SH-SY5Y Cell Line and in NMRI Mice
por: Fliszár-Nyúl, Eszter, et al.
Publicado: (2022) -
Comparative bioavailability study following a single dose intravenous and buccal administration of remdesivir in rabbits
por: Szente, Lajos, et al.
Publicado: (2022)